ACRCelerate Junior Researchers Symposium

JRS logo

ACRCelerate: Colorectal Cancer Stratified Medicine Network

The ACRCelerate Colorectal Cancer Stratified Medicine Network, led by Prof Owen Sansom, is a European-wide consortium of basic and clinical scientists at the forefront of CRC research. The overarching aim of the ACRCelerate project is to generate robust and reproducible preclinical data, using a suite of state-of-the art preclinical models, to de-risk future clinical trials via patient stratification. 

This is primarily aimed at giving more Junior members, associated with the ACRCelerate network, a chance to present their work, however all members of the ACRCelerate consortium and extended community are invited to attend.

The symposium will consist of short talks by PhD students and postdoctoral researchers and breakout sessions for further discussion of specific topics. There will also be an interactive poster session which will allow as many people as possible to share their research.

The plenary lecture will be given by Mathew Garnett, Wellcome Trust Sanger Centre, Cambridge, UK.

Please register using the following link;

Registration for Junior Researchers Symposium

The conference is FREE to attend.

Numbers will be strictly limited to 120, so please register early to ensure a place (Deadline: 20th August).


Please note these are UK TIMES.

Wednesday 1st September

ACRCelerate –Junior Researchers Symposium

Gather.Town & Zoom platforms

Session 1

Introduction & Role of TGFb in colorectal cancer

Chairs: Eoghan Mulholland & Simonetta Leto


Owen Sansom - CRUK Beatson Institute, Glasgow.

Welcome & Overview


Dustin Flanagan - CRUK Beatson Institute, Glasgow.

Epithelial TGFβ moonlights as a bad actor in colorectal cancer.


Callum Beach - University of Oxford.

Will TGFB inhibition improve colorectal tumour response to combination immunoradiotherapy.


Carme Cortina - (IRB) Barcelona.

The emergence of facultative stem cells by TGF-β impairment sustains CRC growth.


Coffee Break

Session 2

EGFR and MAPK signalling

Chairs: Tamsin Lannagan & Carme Cortina


Sudhir Malla- Queens University Belfast.

Ontology-led CRC classification uncovers novel pathway-driven tumour subtypes.


Connor Woolley - University of Edinburgh.

Atypical BRAF Mutation in Colorectal Cancer.

10.55- 11.15am

Simonetta Leto- Candiolo Cancer Institute, Turin.

Exploiting patient-derived xenografts and organoids to tackle apoptotic dependencies in EGFR-inhibited colorectal tumours.


Mark White- CRUK Beatson Institute, Glasgow.

Modelling Braf mutant colorectal cancer in GEMMs. 


Comfort Break


Breakout sessions

A - Models of drug-tolerant cell persistence in colorectal cancer

B - Irradiation: conducting robust pre-clinical experiments

C - Mice & Men: Computational Battle!


Lunch Break


Poster Session


Plenary Lecture (chair: Andrew Campbell)

Mathew Garnett – Wellcome Trust Sanger Centre, Cambridge.

Tumour organoid cultures as a platform for functional genomics.


Coffee Break

Session 3

Tumour microenvironment

Chairs: Mark White & Sudhir Malla


Shania Corry- Queens University Belfast.

Activation of STAT1-mediated antigen processing represents a therapeutic vulnerability that can prevent relapse in stroma-rich colon cancer.


Eoghan Mulholland- University of Oxford.

Colorectal Cancer Cell Communities: Landscape Analysis using multiplex Imaging.


Sara Verbandt- KU Leuven Belgium.

Epithelial subtypes and relationship to T cell infiltrates in colorectal cancer.


Antonia Churchhouse - University of Edinburgh.

Loss of Dock2 increases susceptibility to inflammation-associated colorectal cancer in vivo and is associated with an interferon gamma signature.


Simon Leedham - University of Oxford.

Closing remarks.


Informal Discussions in Gather.Town space



 For further information please email;



Research Mahnoor 290x200

Read more about the Research Groups working at the Beatson Institute.



Seminars 2021

Find out more about our seminars including our Distinguished Seminar Programme.